Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
aav9 carrying the ighmbp2 gene (1 trial)
Tasadenoturev (1 trial)
Glioma (Phase 1)
Trials (2 total)
Trial APIs (2 total)